Atlas Trials

Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression

Clinical trial NCT00186498 · COMPLETED

Trial details

NCT number
NCT00186498
Sponsor
Stanford University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2004-02-01
Primary completion
2006-02-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.